Objective-Gallstone disease has been related to cardiovascular risk factors; however, whether presence of gallstones predicts coronary heart disease (CHD) is not well established. Approach and Results-We followed up 269 142 participants who were free of cancer and cardiovascular disease at baseline from 3 US cohorts: the Nurses' Health Study (112 520 women; 1980-2010) 
G allstones are crystalline deposits in the gallbladder, principally formed by abnormal bile constituents (eg, cholesterol, phospholipids, and bile salts). Gallstone disease is one of the most common and costly gastrointestinal disorders requiring hospitalization in the United States, 1 affecting 5% to 25% adults in the Western world. 2 Gallstone disease has been linked to diverse cardiovascular risk factors, such as obesity, 3 diabetes, 4 and metabolic syndrome. 5, 6 In addition, patients with gallstones are characterized by distorted secretion of bile acids, 7 which play a key role in regulating gut microbiota composition and activity. 8, 9 Gut microbiota may influence a range of host functions related to cardiovascular risk, [10] [11] [12] and metabolites produced by gut microbiota such as trimethylamine N-oxide and L-carnitine have been directly linked with cardiovascular risk. 10, [12] [13] [14] Several previous studies have related a history of gallstone disease to cardiovascular risk. [15] [16] [17] However, some studies had short-term follow-up, did not confirm gallstone cases, or did not account for important covariates such as lifestyle and dietary habits. Notably, most of the previous studies were not conducted in the US population; and data from the US cohorts are lacking.
In this study, we analyzed the relationship between a history of gallstone disease and risk of incident coronary heart disease (CHD) in 3 large prospective US cohorts, followed up for ≤30 years and accounting for a wide spectrum of traditional risk factors. We performed several sensitive analyses to minimize the influence from potential reverse causation and confounding. We also conducted a systematic review of previously published studies and meta-analyzed our results with the published data from other prospective cohorts.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results
At cohort-specific baselines, 14 023 participants out of 225 439 (6.2%) women (Nurses' Health Study [NHS] and NHS II) and 1449 out of 43 703 (3.3%) men (HPFS [Health Professionals Follow-up Study]) reported a history of gallstone disease. Table 1 shows the characteristics of participants by cohort and gallstone status at cohort-specific baselines. Consistently across the 3 cohorts, participants who reported a history of gallstone disease were more likely to be older, current smokers, regular aspirin users, less physically active, to consume less alcohol, to have a higher body mass index, and to have a history of hypertension, diabetes, or hypercholesterolemia (Table 1) .
Across ≤30 years of follow-up, we confirmed 21 265 incident CHD cases. In general, the crude incidence rates of total CHD were nearly double among participants who had reported gallstone disease compared with those who had never reported gallstone disease (Table 2 ). There was a significant age-adjusted association between a history of gallstone disease and CHD risk in each cohort. After multivariable adjustment, the associations between history of gallstones and CHD were largely attenuated but remained significant in each cohort: NHS (hazard ratio [ When we limited the exposure to a history of cholecystectomy only, its association with total CHD risk was similar to when our definition of gallstone disease included both history of gallstones and cholecystectomy (data not shown). In secondary analyses of the total CHD subgroup definitions (fatal or nonfatal myocardial infarction and revascularization), multivariable-adjusted analyses of the individual outcomes revealed significant associations between a history of . However, obesity status and disease status of diabetes mellitus and hypertension significantly modified the association between gallstone disease and CHD risk (all P for interaction <0.05, in the interim meta-analyses of our 3 cohorts; Figure 1 ). Participants with a history of gallstone disease who were not obese, or did not have diabetes or hypertension, seemed to have a greater increased risk of CHD compared with those participants who were obese, did have diabetes mellitus, or hypertension. Age, smoking, dietary quality, physical activity, or hyperlipidemia did not modify the association between history of gallstone disease and CHD. Although the pooled modification effect from physical activity was statistically significant, the direction differed across 3 cohorts. Therefore, we did not conclude physical activity modified the association between gallstone disease and CHD risk. , and daily energy intake (kcal/d in quintiles). In NHS and NHS II, menopausal status (yes/no), postmenopausal hormone uses (yes/no), and uses of oral contraceptive pills (yes/no) were also considered as covariates. The number of cases and incidence rates for the secondary outcomes (fatal and nonfatal MI, and revascularization) does not equal the number of cases for the primary outcome (total CHD), because some participants experienced both MI and revascularization in the same period. For total CHD, the first of these events is considered the incident event at which follow-up ends. CHD indicates coronary heart disease; CI, confidence interval; HPFS, Health Professionals Follow-up Study; HR, hazard ratio; MI, myocardial infarction; NHS, Nurses' Health Study; NHS II, Nurses' Health Study II; and PY, person-year.
Results of Systematic Review and Meta-Analysis
We also conducted a systematic review and meta-analysis to incorporate the results of our 3 cohorts with previously published reports from prospective cohort studies. Our search of English-language articles resulted in 1243 citations from PUBMED and 73 from EMBASE, with 16 duplicates. We screened the titles and abstracts using general inclusion criteria as described in the Materials and Methods section in the online-only Data Supplement. We identified 52 abstracts for further full-text review and eventually included 4 prospective cohorts for final meta-analysis. Together with the current study, a total of 7 cohort studies were included in our meta-analysis. Characteristics of the 7 prospective cohorts included in the meta-analysis are shown in Table I in the online-only Data Supplement. We detected significant heterogeneity among these study results (I 2 =72%, P for homogeneity <0.01), which could be from a wide variation in study characteristics, such as study population, follow-up period, and measurements of gallstone disease and CHD. However, we were unable to detect the sources of heterogeneity because of a relatively small number of studies. Nevertheless, most studies showed directionally consistent associations between gallstone disease and CHD risk. On the basis of data from all cohort studies combined, including 842 553 participants and 51 123 incident cases of CHD, the pooled risk ratio from the random-effects model was 1.23 (95% CI, 1.15-1.33) for those with gallstone disease compared with those without gallstone disease (Figure 2) . In meta-analysis, participants from our 3 internal cohorts with a history of gallstone disease had a 17% increased risk of CHD (HR, 1.17 [95% CI, 1.09−1.26]), whereas participants from external cohorts with a history of gallstone disease had a 30% increased risk of CHD (HR, 1.30 [95% CI, 1.15−1.47]). We also conducted sensitivity analyses excluding the only study that presented an odds ratio estimate, 15 and the pooled risk ratio was 1.23 (95% CI, 1.15-1.33), indicating that the overall results were not influenced by this study. Neither visual inspection of the funnel plot ( Figure I in the online-only Data Supplement) nor the Egger test (P=0.52) suggested publication bias.
Discussion
In our 3 prospective studies of 269 142 women and men, we found that a history of gallstone disease was associated with a 17% increased risk of CHD, independent of traditional risk factors. The associations were consistent in both men and women and modified by obesity and hypertension and diabetes status. Results from the meta-analysis incorporating previously published data from 4 additional prospective cohort studies further confirmed our findings.
One of the first reports on the relationship between gallstone disease and incident cardiovascular disease was by Bortnichak et al, 15 who found that male gallstone patients were at an increased risk of incident CHD, whereas there was no such association in women. Significant associations between gallstone disease and CHD risk were also observed in crosssectional studies 18, 19 and other prospective cohort studies in Asian 17, 20 and German 16 populations. The most recent and largest prospective study to date emerged from the China Kadoorie Biobank study, 20 which involved 199 292 men and 288 081 women, followed up for a median 7.2 years. Authors reported 23% higher risk of ischemic heart disease for participants with gallstone disease at baseline, as compared with those without , nonsmoker, and Alternative Healthy Eating Index [AHEI] and physical activity less than the cohort-specific median value, with normal blood cholesterol levels, without diabetes mellitus and without hypertension). Solid circles indicate the respective stratum with the higher (presumably riskier) values (ie, age ≥55 y, BMI ≥30 kg/m 2 , smoker, AHEI, and physical activity greater than or equal to the cohort-specific median value, with high blood cholesterol levels, with diabetes mellitus and with hypertension). Cox proportional hazards models were adjusted to include age (mo); race (white/nonwhite); family history of myocardial ischemia (yes/no); marital status (married/ not married); smoking status (never smoked, past smoker, current smoker); BMI (kg/m 2 ); physical activity (metabolic equivalent task hours/d in quintiles); diabetes mellitus (yes/no); hypertension (yes/no); hypercholesterolemia (yes/no); regular use of aspirin (yes/no); daily intake of alcohol (0, 0.1-5.0, 5.0-9.9, 10.0-14.9, ≥15.0 g/d), daily intake of the energy-adjusted dietary cholesterol (g/d in quintiles), 2010 AHEI score (in quintiles), and daily energy intake (kcal/d in quintiles). In Nurses' Health Study (NHS) and NHS II, menopausal status (yes/no), postmenopausal hormone uses (yes/no), and uses of oral contraceptive pills (yes/no) were also considered as covariates. the disease, which is an estimated risk consistent with our present results in the US cohorts. As to other cardiovascular outcomes, both ultrasound-diagnosed gallstones and cholecystectomy were related to a 30% higher risk in overall mortality and 49% higher risk in cardiovascular mortality in a large US population, 21 and participants who had gallstone disease had a 28% higher risk in developing ischemic stroke and 33% higher risk in hemorrhagic stroke in a nationwide study in Taiwan. 22 Gallstone disease and CHD share many common risk factors, and it has been challenging to disentangle these shared risk factors from potentially causally linked pathogenesis. Both diseases share multiple common traditional risk factors, including obesity, 3 diabetes mellitus, 4 metabolic syndrome, 5, 6 hypercholesterolemia, 23 hypertension, 23 and an unhealthy diet. 24 In our analyses, the increased risk of incident CHD among gallstone patients was attenuated to a large degree but remained significant after we adjusted for these risk factors, and when we repeated main analyses among populations free of obesity, diabetes mellitus, and hypertension and among those with healthier lifestyle and dietary habits after stratifying by these factors. Our results were similar when we limited the disease to cholecystectomy, and it might suggest that cholecystectomy might not ameliorate the deleterious influence of gallstone diseases on CHD risk. Our observed associations were modified by obesity, diabetes mellitus, and hypertension status, with perhaps counterintuitively stronger associations observed among the presumably healthier subsets of the population, ie, those without obesity, diabetes mellitus, and hypertension. In addition, because cholesterol is the main component of most gallstones and atherosclerotic plaques, and the use of statins seems to prevent gallstone formation, 25 we included hypercholesterolemia as a covariate in our statistical models and also conducted sensitivity analyses among the participants who had normal blood cholesterol levels, as well as among those not taking lipid-lowering medications, and yet the association of gallstone disease and CHD risk remained significant. Taken together, these observations may point to pathways independent of these important risk factors that link gallstone disease to CHD. Further research is warranted to explore potential mechanisms.
The potential mechanisms for the association of gallstone diseases with CHD may, at least, include the primary metabolic pathway and the bacterial pathway. Take an example in the metabolic pathway, among patients with gallstones, especially those with cholesterol gallstones, their bile acid and lecithin secretion rates tend to be depressed and cholesterol secretion rates elevated, 26 which could indicate enhanced cholesterol synthesis and therefore increase cardiovascular disease risk. In the bacterial pathway, gut microbiota dysbiosis may directly link gallstone disease to CHD risk. The presence of gallstones is related to microbiota dysbiosis in gut and biliary tract (maybe via biotransformation of secondary bile acids), 9, 27 for example, an overgrowth of the bacterial phylum Proteobacteria. 9 At the same time, gut microbiota dysbiosis is found to be linked to a wide range of metabolic disturbances, including an increased risk of obesity and cardiovascular disease. [10] [11] [12] [26] [27] [28] Of note, the bacterial link may be a targeted pathway through which diets influence both diseases. For example, circulating trimethylamine N-oxide, which is a gut flora-generated metabolite of red meat intakes, inhibits bile acid transporters in mouse liver and at the same time promotes atherosclerosis. Our results indicate that the gallstone patients who were not affected by obesity, diabetes mellitus, or hypertension had a greater increased CHD risk compared with those who were affected by these diseases. The underlying mechanisms remained to be further explored. Patients with obesity, diabetes mellitus, or hypertension had a higher absolute risk of CHD; therefore, the increased risk attributable to gallstone disease might be relatively less than those without these diseases. In addition, patients with obesity, diabetes mellitus, and hypertension might modify their lifestyle to be healthier after disease diagnosis, and such modifications might also attenuate the relation between gallstone and CHD.
Although this study may not be able to prove a causal relationship between gallstone disease and CHD, the long-term implications of gallstone disease on heart health are important in clinical practice. 28 Patients with gallstone disease should be recommended a multidisciplinary program based on a careful assessment of coexisting cardiometabolic risk factors. Statins have been shown to dissolve cholesterol gallstones, suggesting their potential for a pharmacological therapy for gallstones beyond their well-known benefits on CHD prevention. 25 However, randomized clinical trials are warrant to test the effect of statins on gallstone disease to more clearly address this issue.
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Strengths and Limitations
The major strengths of this study included the large sample size and well-characterized study populations. The sensitivity analyses, including the 4-year lag analysis, minimized the possibility of reverse causality. We also incorporated previously published prospective cohort studies in a meta-analysis to explore the repeatability and generalizability of our results. Nevertheless, our results need to be interpreted in the context of several potential limitations. First, the assessment of gallstone disease in our cohorts was self-reported. However, validation studies in our populations have confirmed that gallstones and history of cholecystectomy were reported with high accuracy (99%) according to validation of medical records. 29, 30 Second, we did not measure in our cohorts insulin resistance or nonalcoholic fatty liver disease, which could be important mediators of the reported associations. This limited our ability to explore underlying molecular mechanisms or pathways. However, our results were similar among participants reporting normal blood lipid levels.
Conclusions
In summary, we observed that gallstone disease is significantly and consistently associated with an increased risk of incident CHD independent of traditional risk factors in both women and men in the United States The combined, metaanalyzed observations from our cohorts and previous prospective cohorts support our results. Our findings highlight the potential implication of gastrointestinal disorders on prevention of cardiovascular disease.
